Does testosterone actually fix low libido in women?

What did @sophiaarudy actually say?

Sophia shared three personal strategies for recovering libido after stopping hormonal birth control: leaning into love languages so you feel emotionally safe with your partner, expanding intimacy beyond sexual acts to include real conversation and connection, and deliberately "setting yourself up for success" through things like spicy books or audio erotica. She also briefly flagged SSRIs as a libido suppressant. None of this was framed as medical advice, and she was careful to keep it personal and anecdotal. That matters when evaluating what she got right.

She also attributed her own libido loss to seven and a half years on hormonal contraception, which she quit four years ago, and described the recovery as an ongoing process. Her framing is honest about that timeline in a way that a lot of wellness content isn't.

Does the science back this up?

More than you might expect, actually. The connection between hormonal birth control and low libido has real mechanistic support, even if the research is messier than advocates on either side admit. The emotional connection piece has solid backing too, though "love languages" as a formal framework is shakier than its popularity suggests.

On birth control: combined oral contraceptives raise sex hormone-binding globulin (SHBG), which binds free testosterone. Lower free testosterone is associated with reduced sexual desire in women. A 2006 study by Panzer et al. in the Journal of Sexual Medicine found that SHBG remained significantly elevated even after discontinuation, which may explain why some women report a prolonged recovery. That tracks with Sophia's "long journey" framing.

On emotional connection: a 2017 meta-analysis by McNulty et al. in Personality and Social Psychology Bulletin found that relationship satisfaction and perceived partner responsiveness independently predicted sexual desire over time, particularly in women. So the idea that feeling loved, safe, and seen actually feeds libido is not just intuition. It has data behind it.

On erotica and mental priming: a 2012 study by Both et al. in the Journal of Sexual Medicine found that attentional focus and explicit sexual stimuli could meaningfully increase genital arousal and subjective desire. Audio and written erotica fit that mechanism. The science on this is thin but directionally supportive.

What did they get wrong (or right)?

The love languages framework deserves some scrutiny here. Sophia says it "will make or break your relationship," which is a strong claim. Gary Chapman's five love languages model is widely cited but has limited empirical validation as a distinct psychological construct. A 2021 study by Mostova et al. in PLOS ONE found that while partner responsiveness matters, people do not reliably sort into the five discrete categories Chapman describes. The underlying idea, that communicating your emotional needs to your partner matters, is solid. The specific framework is more popular than proven.

Sophia's SSRI callout is accurate. A well-documented side effect of selective serotonin reuptake inhibitors is sexual dysfunction, including decreased libido, delayed orgasm, and reduced arousal. This is not controversial in clinical literature. Mentioning it without fear-mongering or telling people to stop their medication is the right call.

What she got genuinely right is the non-linear, effortful nature of libido recovery. Most wellness content implies a quick fix. She does not. That is worth crediting.

What should you actually know?

If your libido dropped after starting hormonal contraception, or after beginning an antidepressant, or for reasons that feel unexplained, those are legitimate clinical concerns worth raising with a provider, not just a lifestyle problem to optimize your way out of. Low libido in women, what clinicians call hypoactive sexual desire disorder (HSDD), has multiple contributing factors: hormonal, psychological, relational, and neurological. One behavioral tip is not going to address all of them.

The SHBG elevation associated with oral contraceptives can persist for months after stopping, which means some women genuinely need time for androgen levels to normalize. If they do not, that is a conversation for a clinician who can evaluate testosterone levels, thyroid function, and other hormonal markers.

Sophia's emotional connection advice is reasonable relationship guidance, but it is not a substitute for a clinical evaluation if low desire is persistent and distressing. The FDA-approved treatments for HSDD in premenopausal women, flibanserin and bremelanotide, exist for a reason. Relationship communication is a good foundation; it is not a treatment plan.